feed,title,long_url,short_url
BioRxiv,A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters,https://biorxiv.org/cgi/content/short/2021.07.06.451301v1?rss=1,https://j.mp/3hYrmor
BioRxiv,"Nonclinical Safety and Immunogenicity of an rVSV-Î”G-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs",https://biorxiv.org/cgi/content/short/2021.07.06.451119v1?rss=1,https://j.mp/3hnKPzO
BioRxiv,T-CoV: a comprehensive portal of HLA-peptide interactions affected by SARS-CoV-2 mutations,https://biorxiv.org/cgi/content/short/2021.07.06.451227v1?rss=1,https://j.mp/2TCvUIW
BioRxiv,SARS-CoV-2 genome sequencing with Oxford Nanopore Technology and Rapid PCR Barcoding in Bolivia,https://biorxiv.org/cgi/content/short/2021.07.06.451357v1?rss=1,https://j.mp/3dQWIvN
BioRxiv,Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 Variants,https://biorxiv.org/cgi/content/short/2021.07.05.451203v1?rss=1,https://j.mp/3ho8OhW
